Carbamate compounds and of making and using same
US9487495B2 · kind B2 · utility
27Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 7, 2013 |
| Grant date | Nov 8, 2016 |
| Priority date | — |
| Expiry date | Jan 28, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This disclosure provides compounds having the structure:wherein L3, R7, Rd and p are defined herein, which are modulators of MAGL and/or ABHD6. Further provided is the use of these compounds as medicinal agents, processes for their preparation, and pharmaceutical compositions that include the disclosed compounds. The disclosure also provides a method of treating a patient in need thereof, where the patient is suffering from indications such as pain, solid tumor cancer and/or obesity comprising administering a disclosed compound or composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.